Unique ID issued by UMIN | UMIN000024786 |
---|---|
Receipt number | R000028240 |
Scientific Title | A study to investigate effects of Peptide ingestion on lowering blood pressure in the subjects with high normal blood pressure or grade 1 hypertension: a randomized, double blind, placebo controlled study. |
Date of disclosure of the study information | 2016/11/21 |
Last modified on | 2017/12/29 12:50:16 |
A study to investigate effects of Peptide ingestion on lowering blood pressure in the subjects with high normal blood pressure or grade 1 hypertension: a randomized, double blind, placebo controlled study.
A study to assess the effects of Peptide ingestion on lowering blood pressure.
A study to investigate effects of Peptide ingestion on lowering blood pressure in the subjects with high normal blood pressure or grade 1 hypertension: a randomized, double blind, placebo controlled study.
A study to assess the effects of Peptide ingestion on lowering blood pressure.
Japan |
None
Not applicable | Adult |
Others
NO
The aim of this study is to evaluate the effect of Peptide ingestion on reducing blood pressure in high-normal blood pressure and grade 1 hypertension adult.
Efficacy
Systolic blood pressure and diastolic blood pressure
Pulse Wave Velocity
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
NO
2
Treatment
Food |
Ingestion of peptide for 12 weeks
Ingestion of placebo for 12 weeks
30 | years-old | <= |
65 | years-old | > |
Male and Female
Subjects with high normal blood pressure (systolic BP from 130 to 139/ or diastolic BP from 85 to 89 mm Hg) or grade 1 hypertension (systolic BP from 140 to 159/ or diastolic BP from 90 to 99 mm Hg)
(1) Subjects who have history or receiving treatment of serious disease
(2) Subject who is under medication for diabetes, hypertension or dyslipidemia
(3) Subject with a history of serious allergy to medicine and food
(4) Subject who is pregnant or under lactation, or who is expected to be pregnant during the study
(5) Heavy smoker and heavy drinker, or subject with irregular lifestyle
(6) Subject who is ineligible due to physician's judgment based on background of subject, physical finding, interview
120
1st name | |
Middle name | |
Last name | Fumiaki Abe |
Morinaga Milk Industry Co., Ltd.
Food Ingredients and Technology Institute
5-1-83 Higashihara Zama-Shi, Kanagawa, Japan
046-252-3070
f_abe@morinagamilk.co.jp
1st name | |
Middle name | |
Last name | Shigeru Imai |
CROee.INC
Evidence Division
2F YS Build. 1-13-23 Minamiikebukuro Toshima-ku, Tokyo, Japan
03-5953-2108
imai@croee.com
CROee.INC
Morinaga Milk Industry Co., Ltd.
Profit organization
NO
2016 | Year | 11 | Month | 21 | Day |
Unpublished
Completed
2016 | Year | 10 | Month | 13 | Day |
2016 | Year | 11 | Month | 21 | Day |
2016 | Year | 11 | Month | 10 | Day |
2017 | Year | 12 | Month | 29 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028240
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |